Melittin [L6,13NLYS; I20NLYS]

General Information


DRACP ID  DRACP03903

Peptide Name   Melittin [L6,13NLYS; I20NLYS]

Sequence  GIGAVXKVLTTGXPALISWXKRKRQQ

Sequence Length  26

UniProt ID  Q95Z19 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C113H189N35O26

Absent amino acids  CDEFHMNY

Common amino acids  GKX

Mass  323007

Pl  12.55

Basic residues  5

Acidic residues  0

Hydrophobic residues  9

Net charge  5

Boman Index  -2958

Hydrophobicity  -19.23

Aliphatic Index  90

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  220

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17462584

Title  Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action

Doi Not available

Year  2007

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14133

DRACP is developed by Dr.Zheng's team.